16 September 2026 · The Pharmacist
Propranolol capsule shortage expected to last until November 2026
A supply shortage of propranolol modified-release capsules is now expected to continue until November 2026. The ongoing disruption affects both the 80mg and 160mg strengths of the modified-release formulation. The updated forecast extends the expected period of constraint for healthcare providers and dispensing teams across the UK.
A medicine supply notification regarding the shortage was originally issued by the Department of Health and Social Care (DHSC) in November 2025. Following subsequent assessments of stock availability, the medicines supply tool hosted on the Specialist Pharmacy Service (SPS) website has been updated to reflect the revised November 2026 re-supply estimate. The notification outlines the ongoing supply challenges across the specified capsule strengths, with SPS providing updates on the situation as timelines evolve.
Healthcare teams are advised to monitor official supply platforms for any further notices or changes regarding stock availability and estimated resolution dates. For UK online pharmacies and digital health brands, this ongoing disruption likely requires operational adjustments to prescribing flows and inventory planning to manage patient requirements across the affected 80mg and 160mg strengths until supplies stabilise.